United Kingdom Pharmaceuticals

Hikma Pharmaceuticals PLC (HIK)

Track

Track

Hikma Pharmaceuticals PLC recorded four insider trading transactions over the past ninety days, all representing purchases. Executives acquired shares totaling 166,761.12 GBP. This activity follows the August 2026 results financiers, occurring while the stock price maintains a positive trend, currently positioned at approximately 69% of its annual range.
Ticker: HIK Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hikma Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Sam Park PDMR
Transaction date
Purchase
Price
385.58
Quantity 61,230
Value £2,119,847
3.4
Julie Hill PDMR
Transaction date
Purchase
Price
333.39
Quantity 89,810
Value £558,602
3.0
Susan Ringdal PDMR
Transaction date
Purchase
Price
318.90
Quantity 25,582
Value £4,066,643
3.1
Tobias Hestler Non-Executive Director Executive Director
Transaction date
Purchase
Price
16.48
Quantity 7,500
Value £123,600
3.4
Julie Hill PDMR
Transaction date
Purchase
Price
14.10
Quantity 178
Value £2,509
3.0
Susan Ringdal PDMR
Transaction date
Purchase
Price
14.10
Quantity 2,337
Value £32,947
3.9
Hussein Arkhagha PDMR
Transaction date
Purchase
Price
14.10
Quantity 407
Value £5,738
3.5
Victoria Hull Non-Executive Chair Director
Transaction date
Purchase
Price
13.76
Quantity 14,455
Value £198,901
3.9
Hussein Arkhagha PDMR
Transaction date
Purchase
Price
12.00
Quantity 6,200
Value £74,400
2.4
Mazen Darwazah Executive Vice Chairman Executive Director
Transaction date
Purchase
Price
14.99
Quantity 100,000
Value £1,498,600
2.4
Mazen Darwazah Executive Vice Chairman Executive Director
Transaction date
Purchase
Price
17.56
Quantity 200,000
Value £3,512,000
3.0
Susan Ringdal PDMR
Transaction date
Sale
Price
19.47
Quantity 3,300
Value £64,251
3.4
Julie Hill PDMR
Transaction date
Purchase
Price
19.03
Quantity 41
Value £780
3.0
Susan Ringdal PDMR
Transaction date
Purchase
Price
19.03
Quantity 621
Value £11,818
3.9
Hussein Arkhagha PDMR
Transaction date
Purchase
Price
19.03
Quantity 206
Value £3,920
2.5
Riad Mishlawi Chief Executive Officer Officer
Transaction date
Purchase
Price
19.03
Quantity 509
Value £9,686
3.6
Bassam Kanaan PDMR
Transaction date
Sale
Price
20.25
Quantity 10,000
Value £202,500
3.6
Bassam Kanaan PDMR
Transaction date
Sale
Price
19.60
Quantity 35,000
Value £686,000
3.4
Julie Hill PDMR
Transaction date
Purchase
Price
19.79
Quantity 59
Value £1,168
3.9
Hussein Arkhagha PDMR
Transaction date
Purchase
Price
19.79
Quantity 297
Value £5,878
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-22 2026-09-21 B Purchase
3.7
Sam Park

PDMR
61,230
385.58
£2,119,847 		61,230 385.58 £2,119,847
2026-09-22 2026-09-21 B Purchase
3.4
Julie Hill

PDMR
89,810
333.39
£558,602 		89,810 333.39 £558,602
2026-09-22 2026-09-21 B Purchase
3.0
Susan Ringdal

PDMR
25,582
318.90
£4,066,643 		25,582 318.90 £4,066,643
2026-08-11 2026-08-10 B Purchase
3.1
Tobias Hestler

Non-Executive Director

Executive Director
7,500
16.48
£123,600 		7,500 16.48 £123,600
2026-05-06 2026-05-05 B Purchase
3.4
Julie Hill

PDMR
178
14.10
£2,509 		178 14.10 £2,509
2026-05-06 2026-05-05 B Purchase
3.0
Susan Ringdal

PDMR
2,337
14.10
£32,947 		2,337 14.10 £32,947
2026-05-06 2026-05-05 B Purchase
3.9
Hussein Arkhagha

PDMR
407
14.10
£5,738 		407 14.10 £5,738
2026-04-28 2026-04-27 B Purchase
3.5
Victoria Hull

Non-Executive Chair

Director
14,455
13.76
£198,901 		14,455 13.76 £198,901
2026-03-11 2026-03-09 B Purchase
3.9
Hussein Arkhagha

PDMR
6,200
12.00
£74,400 		6,200 12.00 £74,400
2025-12-19 2025-12-19 B Purchase
2.4
Mazen Darwazah

Executive Vice Chairman

Executive Director
100,000
14.99
£1,498,600 		100,000 14.99 £1,498,600
2025-08-08 2025-08-07 B Purchase
2.4
Mazen Darwazah

Executive Vice Chairman

Executive Director
200,000
17.56
£3,512,000 		200,000 17.56 £3,512,000
2024-12-23 2024-12-20 S Sale
3.0
Susan Ringdal

PDMR
3,300
19.47
£64,251 		3,300 19.47 £64,251
2024-09-24 2024-09-23 B Purchase
3.4
Julie Hill

PDMR
41
19.03
£780 		41 19.03 £780
2024-09-24 2024-09-23 B Purchase
3.0
Susan Ringdal

PDMR
621
19.03
£11,818 		621 19.03 £11,818
2024-09-24 2024-09-23 B Purchase
3.9
Hussein Arkhagha

PDMR
206
19.03
£3,920 		206 19.03 £3,920
2024-09-24 2024-09-23 B Purchase
2.5
Riad Mishlawi

Chief Executive Officer

Officer
509
19.03
£9,686 		509 19.03 £9,686
2024-08-13 2024-08-09 S Sale
3.6
Bassam Kanaan

PDMR
10,000
20.25
£202,500 		10,000 20.25 £202,500
2024-08-13 2024-08-08 S Sale
3.6
Bassam Kanaan

PDMR
35,000
19.60
£686,000 		35,000 19.60 £686,000
2024-05-09 2024-05-07 B Purchase
3.4
Julie Hill

PDMR
59
19.79
£1,168 		59 19.79 £1,168
2024-05-09 2024-05-07 B Purchase
3.9
Hussein Arkhagha

PDMR
297
19.79
£5,878 		297 19.79 £5,878
Explore more

More insider trading research around Hikma Pharmaceuticals PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600